Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank71
5Y CAGR-10.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-10.9%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$87000.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$155000.00+98.7%
2019$78000.00-70.1%
2018$261000.00+38.8%
2017$188000.00-11.3%
2016$212000.00-